Inflammatory Bowel Disease Flashcards

1
Q

What are the two major forms of inflammatory bowel disease

A
Ulcerative Colitis (UC)
Crohn’s Disease (CD)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the risk factors for IBD

A

Genetics

Environmental Factors:
Smoking (more prevalent in CD)
Diet/obesity
Gut microbiome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Describe the pathogenesis of IBD

A

Potentially due to a defective interaction between the mucosal immune system and the gut flora

  1. Disrupted innate immunity
  2. Uncontrolled inflammation
  3. Physical damage to epithelium and leakiness of tight junctions
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Describe ulcerative colitis (mediators, affected tissues, distribution, continuity)

A

Th2 mediated, dependent on cytokines IL-5 and IL-13
Affects mucosa and submucosa
Always starts in the rectum and spreads proximally
Continuous

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Describe Crohn’s disease (medators, affected tissues, distribution, continuity )

A

Th1 mediated, dependent on cytokine TNF-alpha
Penetrates all the way through the gut
Affects any point in the GI tract – from mouth to anus
Skips lesions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Describe how IBD presents clinically

A
Abdominal pain and crampitng
Diarrhoea, bloody faeces
Bloating
Rectal abscess
Fever
Weight loss
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the first line treatment for IBD patients who present with bloody diarrhoea

A

Fluid/electrolyte replacement

Blood transfusion/iron replacement

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the first line treatment for IBD patients who appear malnourished

A

Nutritional support

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the three classes of drugs used in symptomatic treatment for IBD

A

Glucocorticoids
Aminosalicylates
Immunosuppressives

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are glucocorticoid drugs and give examples of glucocorticoids used in IBD treatment

A

Anti-inflammatory immunosuppressants

Prednisolone, fluticasone, budesonide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Describe the pharmacokinetics of glucocorticoids in IBD treatment

A

High hepatic first pass metabolism means that little active glucocorticoid escapes into the systemic circulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Describe the use of glucocorticoids in ulcerative colitis

A

Aminosalicylates have been proven to be better

Used topically normally and IV if severe

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Describe the use of glucocorticoids in Crohn’s disease

A

Drug of choice in inducing remission

High chance of side effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How are the side effects of glucocorticoids minimised

A

Topical admin
Low dose combinations
Topical/oral admin with first pass metab

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Compare budenoside to prednisolone

A

Budesonide has fewer side effects than prednisolone but prednisolone is better than inducing remission so decisions are made case by case

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Give examples of aminosalicylates used in IBD treatment and where are they absorbed

A

Mesalazine or 5-aminosalicylic acid (5-ASA)

Absorbed in the small bowel and colon

17
Q

What gives aminosalicylates their anti-inflammatory effect

A
Inhibition of IL-1, TNF-alpha and Platelet Activating Factor
Decreased antibody secretion
Non-specific cytokine inhibition
Reduced cell migration (macrophages)
Inhibition of localised immune response
18
Q

Describe the use of aminosalicylate in ulcerative colitis

A

First line in inducing and maintaining remission

19
Q

Describe the use of aminosalicylate in Crohn’s disease

A

Effectiveness is questioned in active disease

Thought to help maintain surgically induced remission

20
Q

Give examples of immunosuppressives used in IBD

A

Azathioprine
Methotrexate
Cyclosporin

21
Q

Describe the use of azathioprine in IBD

A

Maintains remission in CD and some UC patients

22
Q

Describe how azathioprine is activated

A

activated in vivo by gut flora to 6-mercaptopurine (purine antagonist) - interferes with DNA synthesis and cell replication

23
Q

What does azathioprine impair

A

cell- and antibody-mediated responses, lymphocyte proliferation, mononuclear cell infiltration

24
Q

What does azathioprine enhance

A

T cell apoptosis

25
Q

What proportion of patients stop treatment using azathioprine due to side effects and what might these be

A

Pancreatitis
Bone marrow suppression
Hepatotoxicity
Increased risk of lymphoma and skin cancer

26
Q

Which drugs is contraindicated for use with azathioprine

A

Allopurinol (used to treat gout) interacts with Azathioprine

27
Q

What type of drug is methotrexate and what does it do

A

Folate antagonist

Reduces synthesis of purines, interfering with DNA synthesis and replication

28
Q

Give examples of potential curative therapies of IBD

A

Manipulation of the gut microbiome
Biological therapies
Anti-TNF alpha e.g. infliximab
Anti-alpha4-inteferin e.g. natalizumab

29
Q

Describe the manipulation of the gut microbiome in IBD

A

Nutrition Based Therapies (exclusive enteral nutrition EEN)
Probiotic therapy
Faecal Microbiota Replacement Therapies

30
Q

What is rifamixin and how does it work

A

Antibiotic treatment for IBD
Binds to RNA polymerase and interferes with transcription
Induces and sustains remission in moderate CD

31
Q

Describe biological therapies for IBD

A

Anti-TNF-alpha antibodies: Infliximab and Adalimumab
Successful in the treatment of CD - Responds within 6 weeks
Potentially curative
Some evidence of effectiveness in UC

32
Q

What is the mechanism of action of biological therapies for IBD

A

Causes downregulation of many cytokines - reduced leukocyte activation
Induces cytolysis of TNF-alpha cells and apoptosis of activated T cells

33
Q

What are the side effects of using biological therapies for IBD

A

Increased risk of septicaemia
Worsening heart failure
Increased risk of demyelinating disease
Increased risk of malignancy